kotwice text test

Research projects for admissions 2021/2022-4:

Project description:

Title: Poly(A) tails - central hubs of mRNA stability control

Supervisor: Professor Andrzej Dziembowski

Institute: International Institute of Molecular and Cell Biology in Warsaw

Laboratory: Laboratory of RNA Biology

Project description:

Gene expression is regulated at multiple levels. Our lab is interested in the regulation of mRNA stability, especially through the modifications of poly(A) tails. Recently, we have shown that the addition of untemplated uridines to the 3’ end of LINE1 retrotransposons precludes their propagation (Warkocki et al. Cell 2018). Moreover, we have identified a family of poly(A) polymerases TENT5, which reside in the cytoplasm and enhance the expression of mRNAs encoding secreted proteins (Moczek et al. Nature com. 2017; Bilska et al. Nature com. 2020; Gewartowska et al. Cell reports 2021). Those enzymes are differentially expressed in tissues and organs, affecting several aspects of animal physiology. TENT5C is an onco-suppressor in multiple myeloma and control immunoglobulin expression in B cells. TENT5A is essential for collagen secretion, and its mutations lead to congenital bone disease

To study the dynamics of poly(A) tails genome-wide, we have implemented a Direct RNA sequencing Nanopore methodology. It is now widely used in our projects, and we also collaborate with other laboratories interested in post-transcriptional gene expression regulation (for instance, Scheer et al. Nature com. 2021). Moreover, we use Direct RNA sequencing to look globally at the regulation of poly(A) tails (Tudek et al. Nature com., under revision).

In the future, we will continue to study the role and mechanism of action of TENT5 poly(A) polymerases, analyze global control of poly(A) tail lengths and develop bioinformatics tools for Direct RNA sequencing. Finally, we are planning to translate our knowledge out poly(A) tails for the design of mRNAs, which are more stable and better translated, which will be very valuable for mRNA-based therapeutics such as mRNA vaccines.